Abstract
Here, we report the draft genome sequence of Streptomyces albulus strain CCRC 11814, a soil-dwelling, Gram-positive bacterium. S. albulus produces ε-poly-l-lysine, which has diverse antimicrobial activity. The genome is 9.43 Mb in size, with a G+C content of 72.2%, and contains 9,177 protein-coding sequences.
GENOME ANNOUNCEMENT
Members of the genus Streptomyces, the largest genus of actinomycetes, are able to produce an extensive scope of secondary metabolites that are bioactive in a wide range of applications. In the pharmaceutical industry, they produce >67% of naturally derived antibiotics, as well as compounds such as antitumor agents, immunosuppressants, and antifungals (1, 2). The Streptomyces-produced bioactive molecules market is over $30 billion per year (3).
Streptomyces albulus produces a valuable secondary metabolite, ε-poly-l-lysine (PL) (4). PL, a homopolymer consisting of 25 to 30 lysine residues, is active against various microorganisms, including Gram-positive and -negative bacteria, fungi, and phages (5, 6). This antimicrobial activity and its water solubility make it ideal for use as a food preservative.
S. albulus CCRC 11814 was kindly donated by Yoshimitsu Hamano from the Fukui Prefectural University, Japan. Genomic DNA was isolated from a liquid culture using the ZR fungal/bacterial DNA MiniPrep kit (Zymo Research). Genomic DNA paired-end libraries were generated with the NextEra DNA sample preparation kit (Illumina) and indexed using the NextEra index kit (Illumina). Paired-end (2 × 250 bp) sequencing was performed on a MiSeq (Illumina) using the MiSeq reagent kit v2 at the Agricultural Research Council (ARC) Biotechnology Platform. Demultiplexing and quality and adapter trimming were performed with Casava 1.7. A total of 7,866,954 paired-end reads at 174 × coverage were obtained from this workflow. The genome was assembled using the de novo assembly tool in the CLC Genomics Workbench v6 (CLC bio). This assembly produced 242 contigs with an average length of 39,836 bp and an N50 of 79,110 bp. The S. albulus genome is 9.43 Mb in size, with a high G+C content (72.2%) that is similar to that of other Streptomyces species. Genome annotation was performed using the NCBI Prokaryotic Genome Automatic Annotation Pipeline (PGAAP), resulting in 9,177 protein-coding sequences (CDS) being identified. The genome also contains 69 tRNA genes (determined by tRNAscan-SE) and 4 rRNA genes with 1 rRNA operon (16S, 23S, and 5S) located on contig 198 (determined by RNAmmer).
In S. albulus, the amino acid biosynthetic pathway produces l-lysine, which is the precursor for PL production. The initial reaction of amino acid biosynthesis, catalyzed by aspartate kinase, is under feedback regulation by its products. S. albulus is unique in that it does not suffer from this feedback regulation of aspartate kinase and can produce l-lysine, and therefore PL, in high quantities (4). The ultimate step in PL biosynthesis is the polymerization of l-lysine, a reaction catalyzed by ε-poly-l-lysine synthetase. This draft genome sequence will allow for the investigation of these genes and other genes in more detail, thereby allowing us to identify the target genes for metabolic engineering, especially when adapting the strain for industrial bioprocessing and second-generation feedstock utilization (7).
Nucleotide sequence accession numbers.
This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession no. AROY00000000. The version described in this paper is version AROY02000000.
ACKNOWLEDGMENTS
We thank the National Research Foundation (NRF) for its financial assistance.
The opinions expressed and conclusions arrived at are those of the authors and are not necessarily to be attributed to the NRF.
Amanda Dodd received an Innovation Doctoral Scholarship (grant ID 83765, National Research Foundation of South Africa).
Footnotes
Citation Dodd A, Swanevelder D, Featherston J, Rumbold K. 2013. Draft genome sequence of Streptomyces albulus strain CCRC 11814, an ε-poly-l-lysine-producing actinomycete. Genome Announc. 1(5):e00696-13. doi:10.1128/genomeA.00696-13.
REFERENCES
- 1. Bentley SD, Chater KF, Cerdeño-Tárraga A, Challis GL, Thomson NR, James KD, Harris DE, Quail MA, Kieser H, Harper D, Bateman A, Brown S, Chandra G, Chen CW, Collins M, Cronin A, Fraser A, Goble A, Hidalgo J, Hornsby T, Howarth S, Huang C, Kieser T, Larke L, Murphy L, Oliver K, O’Neil S, Rabbinowitsch E, Rajandream M, Rutherford K, Rutter S, Seeger K, Saunders D, Sharp S, Squares R, Squares S, Taylor K, Warren T, Wietzorrek A, Woodward J, Barrell BG, Parkhill J, Hopwood DA. 2002. Complete genome sequence of the model actinomycete Streptomyces coelicolor A3. Nature 417:141–147 [DOI] [PubMed] [Google Scholar]
- 2. Ikeda H, Ishikawa J, Hanamoto A, Shinose M, Kikuchi H, Shiba T, Sakaki Y, Hattori M, Omura S. 2003. Complete genome sequence and comparative analysis of the industrial microorganism Streptomyces avermitilis. Nat. Biotechnol. 21:526–531 [DOI] [PubMed] [Google Scholar]
- 3. van Wezel GP, McKenzie NL, Nodwell JR. 2009. Chapter 5. Applying the genetics of secondary metabolism in model actinomycetes to the discovery of new antibiotics. Methods Enzymol. 458:117–141 [DOI] [PubMed] [Google Scholar]
- 4. Hamano Y, Nicchu I, Shimizu T, Onji Y, Hiraki J, Takagi H. 2007. epsilon-Poly-L: -lysine producer, Streptomyces albulus, has feedback-inhibition resistant aspartokinase. Appl. Microbiol. Biotechnol. 76:873–882 [DOI] [PubMed] [Google Scholar]
- 5. Hamano Y. 2011. Occurrence, biosynthesis, biodegradation, and industrial and medical applications of a naturally occurring ε-poly-l-lysine. Biosci. Biotechnol. Biochem. 75:1226–1233 [DOI] [PubMed] [Google Scholar]
- 6. Shima S, Matsuoka H, Iwamoto T, Sakai H. 1984. Antimicrobial action of epsilon-poly-l-lysine. J. Antibiot. (Tokyo) 37:1449–1455 [DOI] [PubMed] [Google Scholar]
- 7. Rumbold K, van Buijsen HJJ, Gray VM, van Groenestijn JW, Overkamp KM, Slomp RS, van der Werf MJ, Punt PJ. Microbial renewable feedstock utilization: a substrate-oriented approach. Bioeng. Bugs 1:359–366 [DOI] [PMC free article] [PubMed] [Google Scholar]